4//SEC Filing
Turk Joseph E Jr 4
Accession 0001246360-19-000768
CIK 0001333170other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 6:35 PM ET
Size
20.0 KB
Accession
0001246360-19-000768
Insider Transaction Report
Form 4
Turk Joseph E Jr
SVP Commercial Operations
Transactions
- Disposition to Issuer
Common Stock
2019-02-21$30.00/sh−86,401$2,592,030→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−99,711→ 0 totalExercise: $27.89From: 2017-04-09Exp: 2027-03-08→ Common Stock (99,711 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−25,897→ 0 totalExercise: $11.03From: 2013-04-04Exp: 2023-03-03→ Common Stock (25,897 underlying) - Disposition to Issuer
Restricted Stock Unit
2019-02-21−23,286→ 0 totalExercise: $0.00From: 2018-03-09Exp: 2020-03-09→ Common Stock (23,286 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−102,529→ 0 totalExercise: $16.66From: 2015-04-03Exp: 2025-03-02→ Common Stock (102,529 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−7,542→ 0 totalExercise: $18.48From: 2012-04-09Exp: 2019-03-08→ Common Stock (7,542 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−36,958→ 0 totalExercise: $14.66From: 2014-04-10Exp: 2024-03-09→ Common Stock (36,958 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-02-21−178,772→ 0 totalExercise: $15.58From: 2016-04-09Exp: 2026-03-08→ Common Stock (178,772 underlying)
Footnotes (3)
- [F1]Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash.
- [F2]This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.
- [F3]These performance shares were canceled in the Merger in exchange for an amount in cash equal to the product of the total number of performance shares multiplied by the Merger Consideration of $30 per share.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001341403
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 6:35 PM ET
- Size
- 20.0 KB